Response to drug resistant tuberculosis is insufficient and too slowBMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d1969 (Published 28 March 2011) Cite this as: BMJ 2011;342:d1969
- Weiyuan Cui
More than two million cases of multidrug resistant tuberculosis will emerge between 2011 and 2015, with an additional 25 000 cases of extensively drug resistant tuberculosis every year, if the epidemic spreads unchecked, the World Health Organization and partner agencies have estimated.
International agencies called a briefing on 23 March in Geneva to urge world leaders to accelerate action to deal with the pressing issue of drug resistant tuberculosis ahead of world TB day on 24 March.
Multidrug resistant tuberculosis is resistant to at least isoniazid and rifampicin, the two most powerful first line drugs. Extensively drug resistant tuberculosis is caused by strains of multidrug resistant bacilli that fail to respond to certain standard second line drugs. Leaving either form of the disease untreated increases the risk of spread of drug resistant …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial